mebikar has been researched along with Hypertension in 4 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kazakov, YM; Nastroga, TV; Potiazhenko, MM | 1 |
Duma, SN | 1 |
Chutko, LS; Frolova, NI; Surushkina, SY | 1 |
Chutko, LS; Frolova, NL; Surushkina, SIu | 1 |
3 trial(s) available for mebikar and Hypertension
Article | Year |
---|---|
[Efficiency of using the anxiolytic adaptol in the combination therapy of arterial hypertension in women].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Anxiety Agents; Biureas; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Middle Aged; Treatment Outcome | 2013 |
[Psychoautonomic disorders in patients with hypertension, stage I and possibilities of their treatment].
Topics: Adult; Anti-Anxiety Agents; Anxiety; Autonomic Nervous System Diseases; Biureas; Female; Humans; Hypertension; Male; Middle Aged | 2013 |
[Neurocirculatory asthenia: psychoautonomic features and treatment possibilities].
Topics: Adult; Anti-Anxiety Agents; Biureas; Female; Humans; Hypertension; Male; Neurocirculatory Asthenia; Syndrome; Treatment Outcome | 2012 |
1 other study(ies) available for mebikar and Hypertension
Article | Year |
---|---|
TREATMENT OPTIMIZATION IN MANAGEMENT OF COMBINED PATHOLOGY - ARTERIAL HYPERTENSION AND POST-COVID SYNDROME IN ELDERLY PATIENTS.
Topics: Aged; Arginine; Biureas; COVID-19; Humans; Hypertension | 2023 |